Skip to main content

Sands Capital Ventures, LLC

SEC CIK
0001846444
Latest filing
Aug 13, 2026

Holdings in Q2 2023

Holdings as of Jun 30, 2023, filed Aug 15, 2023. Long positions only; changes compare share counts with Q1 2023.

Institution overview
Positions
21
−2 vs. Q1 2023
Portfolio value
$338.1M
−$66.5M (−16.4%) vs. Q1 2023
Filed
Aug 15, 2023
SEC
Holdings of Sands Capital Ventures, LLC in Q2 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
NUNu Holdings Ltd.ORD SHS CL A9,152,548$72.2M21.4%−3,7990.0%ReducedHistory
PATHUiPath, Inc.Stock3,066,569$50.8M15.0%−750,000−19.7%ReducedHistory
DASHDoorDash, Inc.Stock603,512$46.1M13.6%00.0%UnchangedHistory
IOTSamsara Inc.Stock1,543,447$42.8M12.7%−751,329−32.7%ReducedHistory
SNOWSnowflake Inc.Stock215,708$38.0M11.2%+173+0.1%AddedHistory
TXG10x Genomics, Inc.CL A COM481,770$26.9M8.0%00.0%UnchangedHistory
ACRVAcrivon Therapeutics, Inc.COMMON STOCK1,652,605$21.4M6.3%00.0%UnchangedHistory
ABOSAcumen Pharmaceuticals, Inc.COM3,417,075$16.4M4.9%00.0%UnchangedHistory
Olink Hldg AB680710100SPONSORED ADS705,514$13.2M3.9%00.0%Unchanged–
TARSTarsus Pharmaceuticals, Inc.COM260,000$4.70M1.4%00.0%UnchangedHistory
SPRBSpruce Biosciences, Inc.COM787,007$1.69M0.5%00.0%UnchangedHistory
MASS908 Devices Inc.COM237,258$1.63M0.5%−89,169−27.3%ReducedHistory
CADLCandel Therapeutics, Inc.COM811,737$1.02M0.3%00.0%UnchangedHistory
TSHATaysha Gene Therapies, Inc.COM SHS724,873$478.4K0.1%00.0%UnchangedHistory
CPNGCoupang, Inc.CL A8,438$146.8K<0.1%+1,467+21.0%AddedHistory
TOSTToast, Inc.Stock6,287$141.9K<0.1%+1,793+39.9%AddedHistory
DDOGDatadog, Inc.CL A COM1,366$134.4K<0.1%00.0%UnchangedHistory
CRWDCrowdStrike Holdings, Inc.Stock744$109.3K<0.1%−120−13.9%ReducedHistory
ABSIAbsci CorpCOM57,804$87.9K<0.1%00.0%UnchangedHistory
CFLTConfluent, Inc.CLASS A COM1,354$47.8K<0.1%00.0%UnchangedHistory
GTLBGitlab Inc.CLASS A COM658$33.6K<0.1%00.0%UnchangedHistory

Sold out since Q1 2023 (2)

Positions held at the end of Q1 2023 that are gone from this filing.

Positions of Sands Capital Ventures, LLC sold out since Q1 2023
SecurityClassShares in Q1 2023Value in Q1 2023% of portfolio in Q1 2023History
DICEDICE Therapeutics, Inc.COM2,748,970$78.8M19.5%History
KRTXKaruna Therapeutics, Inc.COM58,895$10.7M2.6%History